presents a partial balance sheet for Hargon, Inc., a creator and manufacturer of biotechnology pharmaceutical products, for December 31, 2012 and 2013.
Partial Balance Sheet for Hargon, Inc.(all dollar amounts in millions)(Problem 10.34)
Current AssetsLandBuildings and ImprovementsEquipmentConstruction in ProgressTotal Land, Buildings, and EquipmentLess Accumulated DepreciationTotal Land, Buildings, and Equipment—NetIntangibles Subject to Amortization:Developed Product TechnologyCore TechnologyTrade NameAcquired Technology RightsOther Intangible AssetsTotal Intangibles Subject to AmortizationLess Accumulated AmortizationTotal Intangibles Subject to Amortization—NetGoodwillOther AssetsTotal AssetsDecember 31,2013 11,7123982,7764,2431,2718,688((2,767))35,921,0142,8771,3481903504545,2193,74711,3021,06$33,788December 31,2012$9,2352942,4853,5849587,321((2,283))5,0383,0771,348190—3354,9503,74210,495787$29,287
e. Hargon uses the straight-line amortization method and recognized $370 million of amortization for 2013 . Compute the average total life and average age of Hargon's intangibles subject to amortization for 2013.